These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of rosiglitazone-induced edema: two case reports and a review of the literature. Wang F; Aleksunes LM; Reagan LA; Vergara CM Diabetes Technol Ther; 2002; 4(4):505-14. PubMed ID: 12396745 [TBL] [Abstract][Full Text] [Related]
4. Unilateral edema due to a thiazolidinedione. Bell DS Diabetes Care; 2003 Sep; 26(9):2700. PubMed ID: 12941750 [No Abstract] [Full Text] [Related]
5. [Macular oedema due to rosiglitazone treatment in diabetes mellitus]. Asensio-Sánchez VM; Asensio-Sánchez MJ; Gómez-Ramírez V Arch Soc Esp Oftalmol; 2010 Jul; 85(7):246-8. PubMed ID: 21093714 [TBL] [Abstract][Full Text] [Related]
6. Avandia and your heart. D'Arrigo T Diabetes Forecast; 2007 Jul; 60(8):16. PubMed ID: 17707991 [No Abstract] [Full Text] [Related]
10. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ; Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691 [No Abstract] [Full Text] [Related]
11. Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes? Baskin S; Neher JO; Dodson S; Hoffman R J Fam Pract; 2005 Aug; 54(8):723-4. PubMed ID: 16061064 [No Abstract] [Full Text] [Related]
12. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R Diabetes Care; 2004 Jan; 27(1):256-63. PubMed ID: 14693998 [No Abstract] [Full Text] [Related]
13. Why should we avoid the use of rosiglitazone? Mikhail N South Med J; 2008 Mar; 101(3):329-31. PubMed ID: 18364671 [No Abstract] [Full Text] [Related]
14. [Pioglitazone and the risk of bladder cancer]. Kado T; Usui I; Tobe K Nihon Rinsho; 2016 Apr; 74 Suppl 2():442-6. PubMed ID: 27266132 [No Abstract] [Full Text] [Related]
15. Diabetes drug may be associated with increase in risk of bladder cancer. Stephenson J JAMA; 2011 Jul; 306(2):143. PubMed ID: 21750286 [No Abstract] [Full Text] [Related]
16. [Heart failure while taking glitazones--what do we know today?]. Halbritter R Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1488; author reply 1488. PubMed ID: 19572255 [No Abstract] [Full Text] [Related]
17. Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow. Psaty B US News World Rep; 2007 Jun; 142(20):64. PubMed ID: 17632813 [No Abstract] [Full Text] [Related]
18. Diabetes drugs a problem in heart failure. Harv Heart Lett; 2003 Sep; 14(1):7. PubMed ID: 14505978 [No Abstract] [Full Text] [Related]
19. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs? Buckingham RE; Hanna A Diabetes Obes Metab; 2008 Apr; 10(4):312-28. PubMed ID: 18333890 [TBL] [Abstract][Full Text] [Related]
20. Avandia in perspective. Comarow A US News World Rep; 2007 Oct; 143(11):71. PubMed ID: 17957906 [No Abstract] [Full Text] [Related] [Next] [New Search]